VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.

Molecular and cellular biochemistry

Volumn 361, Issue 1-2, 2012, Pages 39-45

  Zhang, Lei ^a   Wang, Guiying ^b   Wang, Lin ^b   Song, Chenlin ^b   Leng, Y ^b   Wang, Xinhua ^b   Kang, Jiuhong ^b  

^a TONGJI UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HISTONE DEACETYLASE 2; INHIBITOR OF APOPTOSIS PROTEIN; VALPROIC ACID; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASE 2; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; RNA INTERFERENCE; VALPROIC ACID; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 85027921991     PISSN: None     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1085-x     Document Type: Article

References (0)